|
 The Food and Drug Administration also advised healthcare and
laboratory personnel to minimize the use of blood collection tubes
by performing blood draws only if medically necessary and consider
sharing samples between lab departments if specimens are already
available.
The regulator had in June added only sodium citrate tubes to the
shortage list, and had issued an emergency use authorization a month
later for Becton Dickinson's sodium citrate blood specimen
collection tubes to better identify and treat bleeding disorder in
patients with known or suspected COVID-19.
[to top of second column] |
 "The FDA continues to monitor
the current situation to help ensure blood
testing remains available for patients where
testing is medically necessary," the regulator
said, adding it recommends only tubes that are
cleared by the FDA to be used for blood sample
collection.
(Reporting by Leroy Leo; Editing by Vinay
Dwivedi)
[© 2022 Thomson Reuters. All rights
reserved.]
This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
